{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:27:22Z","timestamp":1791268042505,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/shk.0b013e3181ad3195","type":"journal-article","created":{"date-parts":[[2010,1,9]],"date-time":"2010-01-09T02:00:32Z","timestamp":1263002432000},"page":"149-154","source":"Crossref","is-referenced-by-count":68,"title":["HIGH ACTIVITY OF INDOLEAMINE 2,3 DIOXYGENASE ENZYME PREDICTS DISEASE SEVERITY AND CASE FATALITY IN BACTEREMIC PATIENTS"],"prefix":"10.1097","volume":"33","author":[{"given":"Reetta","family":"Huttunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Aittoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simo S.","family":"Oja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Raitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Pertovaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Vuento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heini","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hurme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2119\/2007-00102.Monneret","article-title":"Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.","volume":"14","author":"Monneret","year":"2008","journal-title":"Mol Med"},{"key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism.","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R3-6-20210213","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation.","volume":"364","author":"Schrocksnadel","year":"2006","journal-title":"Clin Chim Acta"},{"key":"R4-6-20210213","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.4049\/jimmunol.164.7.3596","article-title":"Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.","volume":"164","author":"Hwu","year":"2000","journal-title":"J Immunol"},{"key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism.","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.4049\/jimmunol.168.8.3771","article-title":"Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.","volume":"168","author":"Mellor","year":"2002","journal-title":"J Immunol"},{"key":"R7-6-20210213","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.","volume":"129","author":"Sakurai","year":"2002","journal-title":"J Neuroimmunol"},{"key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"R9-6-20210213","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4049\/jimmunol.0803104","article-title":": Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.","volume":"182","author":"Jung","year":"2009","journal-title":"J Immunol"},{"key":"R10-6-20210213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/SHK.0b013e31819714fa","article-title":"Increased plasma kynurenine values and kynurenine: tryptophan ratios after major trauma are early indicators for the development of sepsis.","volume":"32","author":"Logters","year":"2009","journal-title":"Shock"},{"key":"R11-6-20210213","first-page":"209","article-title":"Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma.","volume":"23","author":"Pellegrin","year":"2005","journal-title":"Shock"},{"key":"R12-6-20210213","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R13-6-20210213","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/clinchem\/48.3.579","article-title":"More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC.","volume":"48","author":"Laich","year":"2002","journal-title":"Clin Chem"},{"key":"R14-6-20210213","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365519709168308","article-title":"Mathematical tools for demonstrating the clinical usefulness of biochemical markers.","volume":"227","author":"Boyd","year":"1997","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"R15-6-20210213","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.mad.2006.01.020","article-title":"Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.","volume":"127","author":"Pertovaara","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"R16-6-20210213","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J"},{"key":"R17-6-20210213","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","article-title":"Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?","volume":"20","author":"Mellor","year":"1999","journal-title":"Immunol Today"},{"key":"R18-6-20210213","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-6-20210213","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.62.6.2277-2284.1994","article-title":"Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts.","volume":"62","author":"Gupta","year":"1994","journal-title":"Infect Immun"},{"key":"R20-6-20210213","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1128\/IAI.69.10.6156-6164.2001","article-title":"Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.","volume":"69","author":"Hayashi","year":"2001","journal-title":"Infect Immun"},{"key":"R21-6-20210213","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc5783","article-title":"Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.","volume":"11","author":"Bozza","year":"2007","journal-title":"Crit Care"},{"key":"R22-6-20210213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s430-001-8023-3","article-title":"Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes.","volume":"189","author":"Murr","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"R23-6-20210213","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/978-1-4615-4709-9_72","article-title":"Kynurenine and neopterin in chronic glomerulonephritis.","volume":"467","author":"Martinsons","year":"1999","journal-title":"Adv Exp Med Biol"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00024382-201002000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:04Z","timestamp":1786039744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-201002000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181ad3195","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}